Redcare Pharmacy NV (XTER:RDC) ROCE % : -1.80% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Redcare Pharmacy NV ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Redcare Pharmacy NV's annualized ROCE % for the quarter that ended in Sep. 2024 was -1.80%.

Redcare Pharmacy NV ROCE % Historical Data

The historical data trend for Redcare Pharmacy NV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redcare Pharmacy NV ROCE % Chart

Redcare Pharmacy NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-10.43

-1.25

-12.36

-11.92

-0.90

Redcare Pharmacy NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															5.80	-5.45	-2.19	-0.70	-1.80

Redcare Pharmacy NV ROCE % Calculation

Redcare Pharmacy NV's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-6.35	/	( ( (729.472 - 119.306)	+	(1021.596 - 223.724) )	/ 2 )
	=	-6.35	/	( (610.166	+	797.872)	/ 2 )
	=	-6.35	/	704.019
	=	-0.90 %

Redcare Pharmacy NV's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-14.02	/	( ( (1025.173 - 243.371)	+	(1018.944 - 243.946) )	/ 2 )
	=	-14.02	/	( ( 781.802	+	774.998 )	/ 2 )
	=	-14.02	/	778.4
	=	-1.80 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Redcare Pharmacy NV (XTER:RDC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Redcare Pharmacy NV ROCE % Related Terms

Thank you for viewing the detailed overview of Redcare Pharmacy NV's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Redcare Pharmacy NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Redcare Pharmacy NV (XTER:RDC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SAEYY:USA SHPPF:USA RDCd:UK 0RJT:UK SHOP:Austria

Address

Erik de Rodeweg 11/13, Sevenum, NLD, 5975 WD

Website

https://www.redcare-pharmacy.com/about-us

Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Austria, Switzerland, Netherlands, Belgium, Spain, France, and Italy.

Executives

Theresa Margarete Holler	Board of Directors
Frank Köhler	Supervisory Board
Marc Michael Fischer	Board of Directors
Stephan Weber	Board of Directors
Dr. Björn Söder	Supervisory Board
Jerome Cochet	Supervisory Board
Jan Claudius Pyttel	Supervisory Board